The 112th Annual Meeting of the Japanese Urological Association

Call for Late-breaking & Encore Abstracts

Numerous clinical trials, including both industry-initiated and investigator-initiated studies, are being conducted in Japan and globally. In some of these trials, results become available after the closure of the abstract submission period, while others may have findings presented at international scientific meetings held shortly before the 112th Annual Meeting of the JUA. Such results are undoubtedly of great interest to many urologists.
To facilitate the timely sharing of these significant findings with the association’s members, we have decided to host a Late-breaking & Encore Session during the 112th Annual Meeting.
We warmly invite researchers wishing to present their latest findings to submit abstracts for this session.

Abstract Submission Period

February 4th (Tue.) 〜
Noon, February 18th (Tue.), 2025 (JST)
The abstract submission for the Late-Breaking and
Encore Sessions has been closed.　

Important Points in Submitting Late-Breaking Abstracts

Only a limited number of late-breaking abstracts will be accepted.
The acceptance of abstracts and the assigned presentation dates will be determined by the scientific conference organizer and results will be notified to applicants late March.
Late-breaking abstracts will not be included in the conference program book. They will only be available in the online abstract browsing system and the conference app. We appreciate your understanding.

Abstract Submission Requirements

Language	English
Length	(Abstract Title) Within 160 characters (Abstract Body) Within 1,600 characters * Please include objectives, methods, results and conclusions.
Authors	Maximum of 13 authors (including the first author) * Please list the presenter as the first author.

Language

English

Length

(Abstract Title) Within 160 characters

(Abstract Body) Within 1,600 characters

* Please include objectives, methods, results and conclusions.

Authors

Maximum of 13 authors (including the first author)

* Please list the presenter as the first author.

COI (Conflict of Interest) Disclosure Declaration

The first author of the presentation must disclose all necessary information in the provided COI form at the time of abstract submission.
Please include a COI disclosure slide below in your presentation.
(The slide shown below is a sample, and the format is flexible.)

the slide template for disclosing conflicts of interest

Abstract Topic Categories

Topic Categories

1	Adrenals	12	Neuro-urology
2	Upper tract benign disease	13	Incontinence
3	Kidney transplantation	14	Infertility
4	Renal tumors	15	Andrology
5	Urothelial tumors	16	Sexual dysfunction
6	Urinary reconstruction	17	Infectious disease
7	Prostate cancer	18	Stones
8	Testis tumors	19	Trauma and emergencies
9	Penile cancer	20	Pediatric urology
10	Male LUTS	21	Urethroplasty and genital reconstruction
11	Female LUTS	22	Others

Abstract Submission Page

Submit your abstract here

Inquries for Abstract Submission

Management Office
c/o Congrès Inc.
E-mail:jua2025-ab@congre.co.jp